QuidelOrtho appoints Micah Young as CFO, succeeding retiring Joseph Busky

Filed June 23, 2026 · Period ending June 22, 2026 · ~1 min read

Key Changes

• high

  Micah Young appointed CFO effective July 6, 2026, succeeding Joseph Busky who announced retirement in February. Young brings extensive medtech CFO experience from Masimo (2017-2026), NuVasive, and Zimmer Holdings.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• high

  New CFO's mandate focuses on improving profitability, enhancing cash generation, and creating long-term shareholder value—signaling company's strategic priorities under new financial leadership.

  Exhibit 99.1 verify on EDGAR →
• medium

  Young receives $750,000 base salary, 100% target bonus, $500,000 sign-on bonus, and $6.5M in RSUs vesting over three years. Severance includes 2x salary plus bonus and full equity acceleration upon change-in-control termination.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →